CD81 has subsequently proven critical for entry based on the absence of infection from lack of surface expression, either naturally or through gene silencing [38,41–43], and by inhibition of entry using blocking antibodies or peptide competitors derived from the LEL region [3–7,41,44,45]. Here, CD81 is linked to infection.